CAMBRIDGE, Mass.--(BUSINESS WIRE)--$MCRB--Seres Therapeutics announced it has entered into two research collaborations with leading academic groups to support the development of microbiome therapeutics for Inflammatory Bowel Disease.
Image may be NSFW.
Clik here to view.
Image may be NSFW.
Clik here to view.
Image may be NSFW.
Clik here to view.
Image may be NSFW.Clik here to view.
